Apotex Health Corp. AOTXF
OTC PK
| 06/30/2026 | |||||
|---|---|---|---|---|---|
| Revenue | -25.79% | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -25.79% | ||||
| Cost of Revenue | 6.97% | ||||
| Gross Profit | -43.37% | ||||
| SG&A Expenses | 59.73% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | 135.49% | ||||
| Total Operating Expenses | 23.24% | ||||
| Operating Income | -81.81% | ||||
| Income Before Tax | -102.86% | ||||
| Income Tax Expenses | -73.92% | ||||
| Earnings from Continuing Operations | -110.57% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -110.57% | ||||
| EBIT | -81.81% | ||||
| EBITDA | -77.21% | ||||
| EPS Basic | -110.14% | ||||
| Normalized Basic EPS | -96.78% | ||||
| EPS Diluted | -110.14% | ||||
| Normalized Diluted EPS | -96.78% | ||||
| Average Basic Shares Outstanding | 4.22% | ||||
| Average Diluted Shares Outstanding | 4.22% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||